Keller Grover

Protecting Employees and Consumers

615.864.9771

  • Our Team
  • Practice Areas
    • Whistleblower Actions
    • Employment Violations
    • Antitrust Litigation
    • Consumer Protection
  • FAQs
    • Whistleblower FAQs
    • Employment Law FAQs
    • Antitrust FAQs
    • Consumer Protection FAQs
  • News
  • Contact Us

Medicare & Medicaid Fraud News

Free and Confidential
Case Review 24/7

615.864.9771

Se Habla Español

Keller Grover / News / Healthcare Fraud / Medicare & Medicaid Fraud

Mar 01 2026

CMS Moves to Curb Medicare Advantage Risk Adjustment Fraud

The Centers for Medicare & Medicaid Services (CMS) recently announced a proposed rule that would restrict a widespread billing practice used by Medicare Advantage plans to inflate payments from the federal government. The proposal signals that the government is committed to combating risk adjustment fraud, an area with substantial and growing False Claims Act exposure. What CMS Proposed On January 26, 2026, CMS released its 2027 Advance Notice, which included a proposal to exclude patient … [Read more...]

Oct 04 2024

Report Says Medicare Part C Insurers Are Pocketing Billions Through Risk Adjustment Schemes

Medicare Advantage, or Part C, was created with the idea that private insurers could provide more cost-effective healthcare than traditional Medicare. But while the program has become popular — it’s the largest taxpayer-funded health insurance program in the United States with a $450 billion annual budget and more than 31 million participants — it is losing billions to fraud. As recent False Claims Act settlements and a recent report in the Wall Street Journal show, one of the costliest … [Read more...]

Oct 15 2021

Government watchdog flags risk-adjusted Medicare Advantage payments 

In September, the U.S. Department of Health and Human Services’ Office of Inspector General issued a report raising concerns that some Medicare Advantage companies inappropriately used chart reviews and health risk assessments, or HRAs, to receive higher risk-adjusted payments.  The OIG found that 20 of the country’s 162 MA companies accounted for a disproportionate share of $9.2 billion in payments from diagnoses that were only reported on chart reviews and HRAs. Of the 20 companies, one … [Read more...]

Aug 31 2021

Keller Grover, Constantine Cannon and Kleiman Rajaram Announce Record $90 Million False Claims Act Whistleblower Settlement with Sutter Health

Sutter Health settles closely watched whistleblower lawsuit alleging it violated the False Claims Act by submitting inaccurate and unsupported medical information on tens of thousands of patients enrolled in Medicare Advantage. SAN FRANCISCO, Aug. 31, 2021 /PRNewswire/ -- Keller Grover, Constantine Cannon, and Kleiman Rajaram announce the landmark $90 million False Claims Act settlement against Sutter Health on behalf of their whistleblower client, Kathy Ormsby, over allegations … [Read more...]

Feb 03 2017

Five Ways Hospice Providers Use Terminally Ill Patients to Rip Off Taxpayers

Hospice care is the provision of specialized palliative treatment for terminally ill patients, focused not on curing them but making their last days as comfortable as possible. Hospice has gone from a grassroots movement on the outskirts of the U.S. medical establishment to a massive, multibillion-dollar industry. And as it has come of age, it has increasingly attracted the same type of fraud, waste, and abuse that plagues U.S. healthcare at large. Hospice treatment has been covered by … [Read more...]

  • 1
  • 2
  • Next Page »

Topics

  • Employment News
    • Wage & Hour Violations
    • Wrongful Termination
    • Discrimination & Harassment
  • Whistleblower News
    • False Claims Act
    • SEC Whistleblower Program News
    • CFTC Whistleblower Program News
    • AML Whistleblower Program News
    • NHTSA Whistleblower Program News
    • IRS Whistleblower Program News
    • DOJ Corporate Whistleblower Program News
  • Consumer Protection
    • Privacy News
    • Unlawful Business Practices
  • Antitrust Litigation
    • Monopolization
    • Price-Fixing
  • Facebook
  • LinkedIn
  • YouTube

KELLERGROVER, LLP · 1965 Market St. San Francisco, CA 94103 · 615-864-9771 · info@kellergrover.com
© 2025 KELLERGROVER, LLP. All rights reserved · Disclaimer & Privacy Policy